Cambridge, United Kingdom

Abdelhakim Ben Nasr


Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Abdelhakim Ben Nasr

Introduction

Abdelhakim Ben Nasr is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections. With a total of two patents to his name, his work is recognized for its potential impact on healthcare.

Latest Patents

One of Abdelhakim Ben Nasr's latest patents focuses on the treatment of bacterial infections. This patent details the use of kinin antagonists for preparing a pharmaceutical composition aimed at treating infections caused by various bacteria, including those from the genera Streptococcus, Escherichia, Salmonella, Staphylococcus, Klebsiella, Moracella, Haemophilus, and Yersinia. His innovative approach highlights the importance of kinin antagonists, especially bradykinin antagonists, in addressing these medical challenges.

Career Highlights

Throughout his career, Abdelhakim Ben Nasr has been associated with Actinova Limited, where he has furthered his research and development efforts. His work at this company has allowed him to explore new avenues in pharmaceutical innovation, contributing to advancements in medical treatments.

Collaborations

Abdelhakim has collaborated with notable colleagues, including Lars Björck and Arne Olsén. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Abdelhakim Ben Nasr's contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections, underscore his role as an influential inventor. His innovative patents and collaborations reflect a commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…